DERMACIN
DEAD

Serial Number

90090007

Owner

PureTek Corporation

First Use Date

Jan 1, 1996

Filing Date

Aug 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DERMACIN Trademark

Serial Number: 90090007

DERMACIN is a trademark filed by PureTek Corporation on August 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

PureTek Corporation (182 trademarks)

San Fernando, CA 91340

Entity Type: 03

Trademark Details

Filing Date

August 3, 2020

Registration Date

Not Registered

First Use Anywhere

January 1, 1996

First Use in Commerce

January 1, 1996

Goods & Services

Medicated hair care preparations; Medicated lotions for treating dermatological conditions; Medicated ointments for treating dermatological conditions; Medicated skin care preparations; Acne medications; Adhesive tapes for medical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-inflammatory gels; Anti-inflammatory salves; Anti-inflammatory sprays; Antibacterial cleaners; Antibacterial spray; Antibiotic ointments; Antibiotic tablets; Burn dressings; Dietary and nutritional supplements; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplements for human consumption; Disinfectants for hygiene purposes; Disinfectants for sanitary purposes; Headache treatment preparations; Medicated balms for treatment of post surgical wound care; Medicated bath preparations; Medicated body powder; Medicated cosmetics; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated pre-moistened towelettes; Medicated serums for treatment of post surgical wound care; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin preparation for use in treating post surgical wound care; Medicated sun care preparations; Medicated throat sprays; Medicinal preparations for the mouth and as sprays; Mentholated ointment for medical use; Natural herbal supplements; Nutritional supplement for eliminating toxins from the intestinal tract; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antivirals; Pharmaceutical skin lotions; Prenatal vitamins; Saline solution for medical purposes; Sanitary towels; Sanitizing preparations for hospital use; Sanitizing preparations for use in institutional and industrial areas; Skin lubricants for athletes to prevent skin chafing; Therapeutic agents for weight control and appetite suppression; Therapeutic medicated bath preparations; Therapeutic pharmaceutical for the treatment of post surgical wound care; Vitamin A preparations; Vitamin B preparations; Vitamin C preparations; Vitamin D preparations

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 11, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 11, 2022 ABN2
ASSIGNED TO EXAMINER
Mar 10, 2022 DOCK
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 27, 2021 GNFN
FINAL REFUSAL E-MAILED
Aug 27, 2021 GNFR
FINAL REFUSAL WRITTEN
Aug 27, 2021 CNFR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 25, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 25, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 25, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 24, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 3, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 3, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 3, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2021 CRFA
ASSIGNED TO LIE
Feb 3, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 26, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 26, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 26, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2020 NWOS
NEW APPLICATION ENTERED
Aug 6, 2020 NWAP